Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, octubre 24
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Viemed Healthcare Inc
VMD
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$9.80
-0.12
-1.21%
Últ. Act.: Oct 23, 5:54 AM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 11 días de ahora en mié nov 4th, después del cierre del mercado
Viemed Healthcare Financials
Viemed Healthcare (VMD) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Viemed Healthcare Raises FY2026 Sales Guidance from $312.000M-$320.000M to $314.000M-$320.000M vs $317.300M Est
Viemed Healthcare (NASDAQ:VMD) raises FY2026 sales outlook from $312.000 million-$320.000 million to $314.000 million-$320.000 million vs $317.300 million estimate.
Benzinga Newsdesk
PRO
Viemed Healthcare Q2 EPS $0.07 Misses $0.12 Estimate, Sales $78.097M Miss $78.100M Estimate
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.12 by 41.67 percent. This is a 12.5 percent decrease over earnings of $0.08 per share from
Benzinga Newsdesk
PRO
Viemed Healthcare Raises FY2026 Sales Guidance from $310.000M-$320.000M to $312.000M-$320.000M vs $315.450M Est
Viemed Healthcare (NASDAQ:VMD) raises FY2026 sales outlook from $310.000 million-$320.000 million to $312.000 million-$320.000 million vs $315.450 million estimate.
Benzinga Newsdesk
PRO
Viemed Healthcare Q1 EPS $0.06 Misses $0.09 Estimate, Sales $75.414M Beat $74.400M Estimate
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.09 by 33.33 percent. This is unchanged from the same period last year. The company reported
Benzinga Newsdesk
Earnings Scheduled For May 5, 2026
Benzinga Insights
PRO
Viemed Healthcare Sees FY2026 Sales $310.000M-$320.000M vs $332.550M Est.
Viemed Healthcare (NASDAQ:VMD) sees FY2026 sales of $310.000 million-$320.000 million vs $332.550 million analyst estimate.
Benzinga Newsdesk
